MLR Maelor

RNS Number:3638W
Maelor PLC
10 May 2007



10 May 2007



                     Maelor plc ("Maelor" or the "Company")

              Completion of acquisition of Acorus Therapeutics Ltd


The Board of Maelor plc (AIM: MLR), the specialist critical care company, is
pleased to announce that it has formally completed the acquisition of Acorus
Therapeutics Limited and the placing of 80,000,000 new ordinary shares, raising
#8 million.


Noble & Company Limited were Nominated Adviser and Broker to the placing and
Maelor.


                                    - Ends -


For further information, call:


Maelor plc
Tim Wright - 01244 625150


Noble & Company Limited
Matthew Hall/Sam Reynolds - 020 7763 2200


Financial Dynamics
Billy Clegg/Edward Westropp - 020 7831 3113






                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
ACQBBLFFDEBLBBD

Maelor (LSE:MLR)
Historical Stock Chart
From Nov 2024 to Dec 2024

Maelor (LSE:MLR)
Historical Stock Chart
From Dec 2023 to Dec 2024